Clinical Trial Update: Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating supplementation with omega-3 polyunsaturated fatty acids to modulate lean mass in lung cancer patients on a high-protein…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplement (omega-3 fatty acids)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Lung Cancer | NA | Status: RECRUITING